Results 191 to 200 of about 587,928 (338)
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao+11 more
wiley +1 more source
The role of metabolite sensors in metabolism-immune interaction: New targets for immune modulation. [PDF]
Yang Q, Guo C, Zhang L.
europepmc +1 more source
Abstract Background Tumor‐associated neutrophils (TANs) play a critical role in modulating immune responses and exhibit significant heterogeneity. Our previous study demonstrated that jagged canonical Notch ligand 2 (JAG2)+ TANs were associated with an immunosuppressive microenvironment in high‐grade serous ovarian cancer (HGSOC), but the underlying ...
Chenyang Wang+11 more
wiley +1 more source
HOXB4/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification. [PDF]
Guo E+8 more
europepmc +1 more source
The Ethics of Tax Evasion: A Survey of Administrative Sciences’Students in Yemen
Robert W. McGee+2 more
openalex +2 more sources
The Attitude of Business Students toward the Ethics of Tax Evasion
Lidija Hauptman
openalex +2 more sources
Abstract Background Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming.
Jinhua Jiang+6 more
wiley +1 more source
Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer. [PDF]
Deng D+12 more
europepmc +1 more source
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong+10 more
wiley +1 more source
NSUN2/ALYREF axis-driven m<sup>5</sup>C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. [PDF]
Yang Y+11 more
europepmc +1 more source